S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
SWOG Cancer Research Network
SWOG Cancer Research Network
Bristol-Myers Squibb
Bristol-Myers Squibb
GlaxoSmithKline
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
Radiation Therapy Oncology Group
Merck KGaA, Darmstadt, Germany
Eli Lilly and Company
Intergroupe Francophone de Cancerologie Thoracique
Eli Lilly and Company
UNC Lineberger Comprehensive Cancer Center
University of California, Davis
University of Pittsburgh
Merck KGaA, Darmstadt, Germany
HiberCell, Inc.
Alliance for Clinical Trials in Oncology
Hoosier Cancer Research Network
Merrimack Pharmaceuticals
Stanford University
Alliance for Clinical Trials in Oncology
Eli Lilly and Company
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Boehringer Ingelheim
National Cancer Institute (NCI)
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
University of Chicago
Accelerated Community Oncology Research Network
SWOG Cancer Research Network
SCRI Development Innovations, LLC
Eli Lilly and Company
Massachusetts General Hospital
Eli Lilly and Company